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Dedication. This paper and the Membrane Protein Data 
Bank celebrate the 20
th anniversary of the landmark pa-
per in Nature (1985, 318: 618–624) describing the first 
‘high-resolution’ three-dimensional structure of a mem-
brane protein, the photosynthetic reaction center from 
Rhodopseudomonas (Blastochloris) viridis.
Abstract. The Membrane Protein Data Bank (MPDB) 
is an online, searchable, relational database of structural 
and functional information on integral, anchored and pe-
ripheral membrane proteins and peptides. Data originates 
from the Protein Data Bank and other databases, and from 
the literature. Structures are based on X-ray and electron 
diffraction,  nuclear  magnetic  resonance  and  cryo-
electron microscopy. The MPDB is searchable online by 
protein  characteristic,  structure  determination  method, 
crystallization  technique,  detergent,  temperature,  pH, 
author, etc. Record entries are hyperlinked to the PDB 
and  Pfam  for  viewing  sequence,  three-dimensional 
structure and domain architecture, and for downloading 
coordinates.  Links  to  PubMed  are  also  provided. The 
MPDB is updated weekly in parallel with the Protein 
Data Bank. Statistical analysis of MPDB records can be 
performed and viewed online. A summary of the statistics 
as applied to entries in the MPDB is presented. The data 
suggest conditions appropriate for crystallization trials 
with novel membrane proteins.
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1  Introduction
As cellular gatekeepers, membrane proteins play a vital 
role in the life of the cell. However, when discussing 
membrane proteins, a common lament has been that there 
are too few known structures upon which to base general 
statements regarding the relationship between structure 
and function. The situation is steadily improving, and the 
field must now reckon with a rising number of solved 
structures. Up to now, when all we had was a handful, the 
membrane protein structure web sites from the laborato-
ries of H. Michel (http://www.mpibp-frankfurt.mpg.de/
michel/public/memprotstruct.html)  and  S. White  (http:
//blanco.biomol.uci.edu/Membrane_Proteins_xtal.html) 
were  extremely  useful.  However,  with  the  growth  in 
numbers of structures there exists a need for an online, 
searchable relational database of such data. This has been 
realized in the Membrane Protein Data Bank (MPDB; 
http://www.lipidat.chemistry.ohio-state.edu/MPDB/
index.asp), a description of which is presented here. 
At the heart of the MPDB is an MPDB record, with at 
least one for each protein or peptide in the database. The  * Corresponding author.Cell. Mol. Life Sci. 63 (2006) 36–51
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contents of the MPDB record draw heavily on the corre-
sponding Protein Data Bank (PDB, http://www.rcsb.org/
pdb/ ) record [1]. However, the former brings together 
in a convenient format information of direct interest to 
the membrane structural and functional biologist. Such 
information is generally not immediately accessible in 
the  PDB  record. The  MPDB  record  is  also  resourced 
with a host of direct links to related information (struc-
ture, sequence, coordinates, etc.) bearing on the protein 
of interest.
The PDB is an extraordinarily useful and complete re-
source. However, its focus is on protein structure regard-
less of the identity or type of protein. Thus, its current 
panel of ~31,000 records covers all types from soluble 
to membrane and structural proteins. To cull informa-
tion on the membrane protein subset requires that the 
user perform a search of these records. But, the query 
tool available at the PDB is not discriminating enough, 
and a text search under ‘membrane’ elicits close to 2000 
hits. In contrast, however, the current literature refers to 
structures of a mere 50–60 different membrane proteins. 
To what, then, can we attribute the disparity? It arises in 
part from the limited descriptors used by authors to an-
notate entries in the PDB and to the indiscriminate nature 
of the search tools provided. The disparity is also due to 
the limiting criteria used when enumerating membrane 
proteins of known structure. Thus, for example, the 2000 
records  referred  to  above  include  soluble  membrane 
protein fragments. They also include proteins that inter-
act with membrane proteins but that are not themselves 
membrane proteins. The MPDB was designed to avoid 
these shortcomings and to provide a resource specific to 
membrane proteins and peptides. 
Our original intent was to limit the scope of the MPDB 
to bone fide membrane proteins. These include the classi-
cally defined polytopic proteins that cross the membrane 
several times as well as the bitopic type that cross it just 
once (fig. 1). In the interests of completeness, the data-
base has been extended to include monotopic and pe-
ripheral proteins. The former include proteins which are 
anchored in but do not cross the membrane. In addition 
to proteins, the data bank also hosts polypeptides, many 
of which are antimicrobial agents. 
An early version of the MPDB included only structures 
solved by X-ray crystallography as applied to three-di-
mensional (3D) crystals. Again, in the interests of com-
pleteness the data bank has been extended to structures 
determined  using  electron  diffraction,  cryo-electron 
microscopy  and  nuclear  magnetic  resonance  (NMR). 
The spatial resolution limit for inclusion in the MPDB 
is 10 Å. 
While the scope of the MPDB is thus broad, the fact that 
it is housed in a relational database means that it can be 
selectively searched for particular subsets of membrane 
protein types. It can also be readily updated. The intent is 
to do so in parallel with the PDB on a weekly basis. 
Another  attractive  feature  of  the  relational  nature  of 
the MPDB is that the data therein can be processed and 
analyzed with ease. Accordingly, the data bank includes 
a section titled ‘Statistics’. These take the form of fre-
quency histograms where a range of parameters, such as 
crystallization method, detergent, temperature, etc., used 
for structure determination are shown along with their 
absolute and relative frequencies of use. The statistics 
are performed on the most recent update of the database. 
While not gone into in great detail here, the Statistics 
feature enables the interested user to mine the MPDB 
for important trends and relationships. The hope is that 
this will be used to facilitate more rational and successful 
structure elucidation strategies and to provide a succinct 
summary of what has been accomplished in the field and, 
by extension, what remains to be done.
The  paper  is  organized  as  follows. We  begin  with  an 
overview of how the database was constructed and of 
the criteria used for record inclusion. The database itself 
is introduced next, beginning with a description of an 
MPDB record. This leads into an outline of the various 
search options available for querying the MPDB. The 
online statistical analysis feature and what the data tell 
us about conditions conducive to membrane protein and 
peptide structure determination are described next. The 
paper ends with a view to future MPDB developments.
2  Methods
2.1  Record source and criteria for inclusion
All  records  in  the  MPDB  have  a  corresponding  PDB 
record. An initial search of the PDB under ‘membrane 
protein’ produced close to 660 records. These records 
were evaluated individually, and a decision was made as 
to their suitability for inclusion in the MPDB based on 
criteria identified below. Unfortunately, such a search is 
error prone and can fail to flag bone fide membrane pro-
Figure 1. Cartoon representation of the membrane topologies fea-
tured in the MPDB. Thin horizontal lines demark the membrane in 
and on which the protein (bold lines) sits. The simplest polytopic 
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tein records where, for example, the record is identified 
as referring to a membrane channel or transporter instead 
of a membrane protein. Accordingly, the search was ex-
panded to include all entries containing ‘membrane’ and 
these too were evaluated individually as above. 
Once a record was identified as relevant, its header file 
was downloaded from the PDB. Appropriate data were 
copied  from  the  header  and  pasted  into  the  MPDB 
record. As much as possible, obvious spelling and punc-
tuation errors in the original record were corrected at this 
stage. Data that were ambiguous or unavailable in the 
PDB record were retrieved from the source literature and 
related databases by the MPDB curators and entered into 
the MPDB record. The Pfam designation and crystalliza-
tion conditions are two such examples (see section 3.1.2). 
Occasionally, incomplete data were reported in the PDB 
record, as, for example, when PEG is identified as the 
precipitant without reference to its molecular weight and 
size distribution. If the relevant information was easily 
available in the source literature it was retrieved and en-
tered in the MPDB record. 
As noted, there are extant web sites that contain membrane 
protein structure data that are based on the PDB. These 
include the Michel (http://www.mpibp-frankfurt.mpg.de/
michel/public/memprotstruct.html),  the  White  (http:
//blanco.biomol.uci.edu/Membrane_Proteins_xtal.html) 
and the PDB TM (http://pdbtm.enzim.hu/index.php) sites 
[2]. In the interests of completeness, it was verified that 
data in the MPDB included all proteins reported in these 
sites. Our own knowledge of the field, coupled with sepa-
rate literature searches, was used with a view to being all-
inclusive. We do acknowledge, however, that omissions 
and other errors may have occurred, and we are anxious 
to have these brought to our attention so that they may be 
included or corrected in the next MPDB update. 
The  focus  of  the  MPDB  is  obviously  on  membrane 
proteins.  Clearly,  all  integral  membrane  proteins  are 
included as are the so-called monotopic proteins. These 
are proteins that associate with the membrane without 
crossing it completely. Accordingly, they are anchored 
in the membrane to varying degrees and include proteins 
such as prostaglandin H synthase and fatty acid amide 
hydrolase. There are proteins such as the annexins that 
also associate with membranes. However, these were not 
included in the MPDB for the reason that their associa-
tion is dependent on calcium ions. In other cases, such as 
with cytochrome c, while association with a membrane 
is  possible,  interaction  appears  to  be  at  the  interface, 
with little penetration into the hydrophobic interior of 
the membrane. While this type of protein has not been 
included here, version 2 of the MPDB will accommodate 
such membrane-associating proteins. Cytochromes P450 
are another interesting group of proteins. Some are an-
chored in the membrane. However, to crystallize them 
the anchor was removed. In cases where this produced a 
truly water-soluble fragment, the record was not included 
in the MPDB. When detergents were required to solu-
bilize the protein as part of the crystallization process, 
the record was included in the database. In certain cases, 
organic solvents were required to solubilize the protein or 
peptide. These, too, have been added to the database. 
Another difficulty arose in deciding whether to include 
water-soluble  fragments  and  water-soluble  subunits  of 
membrane proteins. The decision was made against in-
clusion. Thus, neuraminidase and leader peptidase, both 
of which are integral membrane proteins, have had their 
extramembranal parts cleaved and the resulting soluble 
entity crystallized and used in structure determination. 
These are not in the MPDB. The soluble F1 domain of the 
F1F0-ATPase (PDB ID: 1BMF) and the cytoplasmic do-
mains (1N9P, 1QRQ) of the potassium channel are other 
examples of records that, for the same reasons, have not 
been included either. 
While  the  emphasis  is  on  proteins,  polypeptides  and 
protein fragments have also been accommodated in the 
MPDB. The acceptance criteria include the fact or the 
suspicion  that  the  peptide  is  in  or  strongly  associates 
with  the  membrane.  Accordingly,  the  pore-forming 
pentadecapeptide gramicidin is in the MPDB. Magainin 
and melittin, both amphipathic peptide toxins, have also 
been included. We have chosen to accept such entries as 
pertain to fragments of membrane proteins that are mem-
brane-bound such as a transmembranal helix from bovine 
rhodopsin (1FDF) and glycophorin (1AFO).
Hemolysin (7AHL) is an interesting case in that it starts 
out life as a water-soluble protein. An active form of 
the multimeric protein for which there is a 3D structure 
punches holes in target membranes and is a bone fide 
integral membrane protein. For this reason, it is in the 
MPDB. 
We have included in the MPDB all records that satisfy the 
above criteria without regard to resolution (up to a limit of 
10 Å) or indeed method used for structure determination. 
Thus,  photosystem  II  from  Synechococcus  elongatus, 
which  was  solved  to  3.8 Å  resolution  and  which  only 
shows the Ca coordinates, is included in the interests of 
completeness.  Structures  determined  using  X-ray  and 
electron diffraction, cryo-electron microscopy and nucle-
ar magnetic resonance are part of the MPDB. Of course 
the method used is embedded in the record. Thus, for 
those interested in structures based on a particular method 
or to within a specified resolution range, a suitable search 
can be conducted to extract the relevant records. While 
the PDB houses theoretical/predicted membrane protein 
structures  (http://www.rcsb.org/pdb/cgi/models.cgi), 
these are not in the current version of the MPDB.
2.2  Database architecture
The MPDB has a three-tier architecture. It includes a cli-
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The client tier presents data to the user and accepts user 
input which it then passes to the application-server tier. 
Since the latter is a web-based application, it takes the 
form of the web browser, for example, Microsoft Internet 
Explorer. The application-server tier is where the web 
server resides, and it incorporates the rules of the applica-
tion. It is responsible for accepting input from the user, 
evaluating the input against application logic and passing 
it on to the data tier. Furthermore, it receives information 
from the data tier and passes it back to the client tier. The 
current application uses an Internet Information Services 
(IIS) server, and rules are implemented in VBScript, Java-
Script and ASP. The final data-server tier is responsible for 
data storage and for accepting and sending information to 
the application-server tier. Data are currently stored in a 
Microsoft Access relational database. Given the limited 
size of the current data set, the database architecture was 
designed in the interests of rapid retrieval rather than stor-
age capacity. Thus, the MPDB allows fast access and re-
trieval of records from even complex customized queries 
because the primary key for most tables is the PDB ID. 
3  Results and discussion
3.1  The MPDB
A description of the database, its contents and how to use 
it follows. Before proceeding however, some common 
elements in the database will be described.
Banners
The top and bottom of all pages in the MPDB have the 
following banner:
MAIN  PAGE  |  SEARCH  |  STATISTICS  |  USEFUL 
SITES | CONTACT US
The first three elements return the user to the Main Page, 
the Search page and the Statistics pages, respectively. 
This  feature  avoids  the  need  to  use  the  browser  back 
button repetitively to return to the chosen page from deep 
within the database. The fourth element is a link to Useful 
Sites. It links to a treasure trove of web-based databases 
and resources concerned with membranes, proteins, lipids 
and surfactants. The final element Contact Us enables the 
user to communicate with MPDB staff via e-mail. 
For the convenience of the user, across the top and bot-
tom of each MPDB record is the following banner: 
PDB SUMMARY | VIEW STRUCTURE | SEQUENCE 
AND  SECONDARY  STRUCTURE  |  MATERIALS 
AND METHODS | FILE DOWNLOAD/DISPLAY 
It provides direct links to various resource sites within 
the corresponding PDB record. These include the record 
Summary page, the Structure Viewing page, the Se-
quence and Secondary Structure page, the Materials 
and Methods page, and finally the page where the entire 
PDB record, with or without coordinates, can be down-
loaded or displayed. 
N/A
Throughout the database the abbreviation ‘N/A’ is used 
to denote ‘not applicable’, ‘not available’ and ‘not any’ 
(none). It is used variously to indicate that information 
of the type listed is either not applicable to the record 
of interest or is not available in the corresponding PDB 
record or literature. Thus, for example, some of the early 
entries in the PDB failed to indicate the pH at which 
crystals were grown. In such cases, N/A appears in the 
MPDB record under pH. ‘Not any’ is implied when, for 
example, a structure was solved by XRD, but non-protein 
components (other than water) are not observed in the 
model. In this case, all three attributes under Non-Protein 
Components in Structure are assigned values of N/A. 
Not Used
Occasionally, attributes will bear the ‘Not Used’ descrip-
tor. This caters to situations where the particular attribute 
was not employed. For example, for certain NMR-based 
records, lipid was not used in structure determination. In 
this case, the Lipid Used in Bilayer Crystallization/NMR 
attribute will have the Not Used descriptor. Another ex-
ample concerns pH. In situations where a buffer was not 
employed, the Not Used descriptor is entered under pH.
3.1.1  The Main Page
The MPDB is accessed by way of the Main Page (fig. 2) 
when  the  following  URL,  http://www.lipidat.chemist
ry.ohio-state.edu/MPDB/index.asp,  is  submitted.  It  is 
from the Main Page that the user can access the Search 
options page or proceed to examine a host of facts and 
figures about records in the database by way of the Sta-
tistics link. Alternatively, the Quick Search option can 
be used directly. This enables the user to enter the name 
(or the first few letters of the name or a synonym) of the 
protein of interest or a PDB ID, having activated the ap-
propriate radio button, and to find relevant records in the 
MPDB. This generates a summary table from which the 
user chooses the record of interest. 
The  Main  Page  also  provides  summary  information 
about  current  holdings  in  the  MPDB.  Listed  here  are 
the total number of records in the MPDB, and the total 
number of records for unique proteins or peptides and 
families.  ‘Current  Holdings’  values  are  updated  auto-
matically on a weekly basis.
Separate links are included on the Main Page that take 
the user to a brief introduction to the MPDB and to the 
individuals associated with the creation and maintenance 
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3.1.2  The MPDB record
All searches ultimately lead to an MPDB record (fig. 3). 
Currently, there are 539 unique record entries in the data 
bank. A fraction of the information in each was obtained 
automatically,  by  means  of  a  script,  from  the  source 
record in the PDB. 
Each record is headed by a title taken verbatim from the 
PDB record. Below this is the PDB identification code, 
which is hyperlinked to the corresponding record in the 
PDB. The remainder of the MPDB record is divided into 
the following sections. 
3.1.2.1  Protein Characteristics
3.1.2.1.a Name  This is the name of the protein associ-
ated with the corresponding structure record in the PDB. 
Unfortunately, there is little consistency in the protein-
naming process, and the list includes a mix of common 
names and more formal designations.
3.1.2.1.b Size  Proteins and peptides in the database have 
been categorized based on size, which roughly refers to 
number of amino acid residues. The terminology used 
follows the IUPAC Gold Book recommendations (http://
www.chemsoc.org/chembytes/goldbook/). Peptides with 
fewer than 10 residues are designated oligopeptides (no 
entries as of this writing), while polypeptides are 10–100 
amino acids long. Generally, proteins are designated as 
having in excess of 100 residues as a monomer or as a 
multisubunit complex. We have included under Size an 
additional category called Protein Fragment. This refers 
to  proteins  that  have  had  a  sizable  part  of  their  total 
mass removed or that do not have a full complement of 
subunits, to facilitate crystallization or NMR structure 
determination,  for  example.  OmpA  (1QJP)  and  NalP 
(1UYN) were both crystallized as fragments that retained 
the transmembrane part only. The two-subunit complex 
of cytochrome c oxidase (1AR1) is another example of 
what we have classified as a fragment. 
3.1.2.1.c Function  The functional activity of the pro-
tein is indicated here and was obtained directly from the 
PDB and/or from the literature. 
3.1.2.1.d  Family  Family  designation  is  based  on  the 
International Union of Biochemistry and Molecular Biol-
ogy (IUBMB) classification for enzymes and transporters. 
Where Enzyme Commission (EC) and Transporter Classi-
fication (TC) identifiers were available, they have been in-
cluded in the entry. When such designations were not avail-
able, a family description has been provided by the database 
curators based on the name and function of the protein. 
3.1.2.1.e Pfam  Pfam (http://www.sanger.ac.uk/Software/
Pfam/index.shtml) is a database of protein domain clans 
and families. Proteins can consist of one or several do-
mains many of which have been identified and assigned 
a Pfam code. Codes associated with a sizable fraction of 
the records in the MPDB (483 out of 539) were found by 
querying the Pfam database based on the corresponding 
PDB ID or the protein amino acid sequence and were 
entered under Pfam in the MPDB record. They are hy-
perlinked back to the Pfam database, where a complete 
description of the domain and its interactions and com-
plexes is given.
Figure 2. The MPDB Main Page.40  P. Raman, V. Cherezov and M. Caffrey  Membrane protein data bank Cell. Mol. Life Sci.    Vol. 63, 2006  Review Article  41
3.1.2.1.f Disposition in Membrane  Disposition refers 
to the topology of the protein with respect to the mem-
brane in or on which it sits. Four membrane disposition 
types have been created (fig. 1). The first is designated 
anchored or monotopic, where the protein is embed-
ded in but does not cross the membrane. The second 
is of the peripheral type, where the protein is loosely 
associated with the membrane. Cytochrome P450, b-
glucosidase  (1VFF)  and  the  juxtamembrane  domain 
of  the  epidermal  growth  factor  receptor  (1Z9I)  are 
currently the only entries in this group. The third cat-
egory includes transmembranal proteins of the bitopic 
type which cross the membrane just once. This group 
includes a host of peptides and protein fragments, and 
it consists mostly of NMR structures. Transmembranal 
proteins of the polytopic type that cross the membrane 
more than once form the last and most populous of all 
the categories. 
3.1.2.1.g  Secondary  Structure  of  Transmembranal 
Domain  This  characteristic  refers  to  the  dominant, 
secondary  structure  of  the  membrane-crossing  part  of 
the protein. The two major categories are a-helical and 
b-sheet, the latter typically in the form of a b-barrel. 
Helical-barrel  is  a  third  category  that  accommodates 
the several gramicidin records. And finally there is the 
N/A category, which covers peripheral and monotopic 
proteins. 
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3.1.2.1.h Number of Membrane Crossings  Since this 
is an important characteristic of integral membrane pro-
teins, the relevant data have been enumerated by us and 
annotated for each transmembranal protein in the data 
bank. The number of crossings, as helices or strands, is 
reported on a per monomer basis for homomultimeric 
proteins, such as LH2. In the case of heteromultimers, 
cytochrome c oxidase, for example, the number of cross-
ings is for the entire complex. Other illustrative examples 
include  the  homotetramer  aquaporin  1  (1J4N).  Each 
aquaporin monomer has 6 transmembrane helices and 2 
membrane-embedded helices. Accordingly, the reported 
number for this entry is 6. The ClC channel (1KPL) is a 
homodimer. Each monomer has totally 18 a-helices, but 
only 10 span the membrane. The reported number is 10.
Occasionally,  a  membrane  crossing  occurs  by  means 
of a long helix with a short break. In the MPDB, this 
is counted as a single crossing. The crossing extending 
from residue 121 to 143 in the Na
+/H
+ antiporter NhaA 
(1ZCD) is one such example. 
3.1.2.1.i Quaternary Structure in Vivo  The native qua-
ternary structure of a protein, if known, is entered here. 
Examples include homodimers and heteropentamers as in 
the case of the ClC chloride channel (1KPL) and the nico-
tinic acetylcholine receptor (2BG9), respectively.
3.1.2.1.j Source Organism  This section contains the Latin 
name of the species of organism from which the protein 
or peptide was obtained directly, or by means of homo- or 
heterologous expression. The list also includes viruses. 
The sequence of synthetic and recombinant proteins and 
peptides used for structure determination is usually based 
on that of a natural homolog. In this case, the relevant 
source is identified under Source Organism.
3.1.2.1.k Expression System  The bulk of the entries in 
the MPDB refer to proteins produced using recombinant 
DNA technology. This requires a homo- or heterologous 
expression system of which there are 16 types represent-
ed in the MPDB, as of this writing. The Latin name of the 
organism in which the expression was done is identified 
here. One of the options within this category is identified 
as ‘Native’. This refers to proteins that were produced 
in the native organism and which are not recombinant 
proteins. The list includes ‘Synthetic’, which refers to 
‘man-made’ peptides whose sequence is based on that of 
a natural protein or peptide. 
3.1.2.2  Structure Details
3.1.2.2.a Experimental Technique  The method used for 
structure determination is identified here. The methods 
available include cryo-electron microscopy, electron dif-
fraction, nuclear magnetic resonance (NMR) and X-ray 
diffraction (XRD).
3.1.2.2.b Space Group  This feature is relevant only to 
structures solved by means of diffraction. The value is 
obtained directly from the corresponding PDB record.
3.1.2.2.c Resolution  The spatial resolution with which 
the structure was solved is provided here. Values are re-
ported for all entries with the exception of those based on 
NMR, for which the N/A designation is applied. 
3.1.2.3  Crystallization / Solubilization / Data Collec-
tion Conditions
3.1.2.3.a  Method  This  refers  to  the  procedure  by 
which crystals were grown for use in structure deter-
mination. The vast majority of the information entered 
here was obtained by us from the literature since it 
is not always found in the PDB, especially in older 
records. The descriptors employed by the authors of 
the source articles are used. Obviously, for structures 
determined  by  non-crystallographic  means,  the  N/A 
descriptor is used.
3.1.2.3.b Temperature  For  structures  solved  by  crys-
tallographic  means,  this  refers  to  the  temperature  at 
which crystallogenesis was performed. For NMR-based 
structures, it is the temperature at which NMR data were 
collected.
3.1.2.3.c pH  For structures solved by crystallographic 
means, this refers to the pH at which crystallogenesis was 
performed. For NMR-based structures, it is the pH of the 
solution used for NMR data collection. 
3.1.2.3.d Detergent Used in Solubilizationn/NMR   Deter-
gents are invariably used at one or several stages during 
structure determination for purposes of protein solubi-
lization from the source membrane or inclusion body. 
Thus,  the  detergent  identified  is  the  one  employed  in 
crystallogenesis when applied to XRD structures. In the 
case of NMR structures, it generally refers to the deter-
gent used to solubilize the peptide or protein for solution 
NMR data collection. 
3.1.2.3.e Additive Used in Crystallization  Crystalliza-
tion protocols typically require the inclusion of what are 
loosely referred to as ‘additives’ that are often small am-
phiphiles. Ethylene glycol, heptanetriol, EDTA, dithio-
threitol, as well as small amounts of NaCl are examples 
of typical additives. D2O, used in the crystallization of 
BtuCD (1L7V), is another example. 
3.1.2.3.f Precipitant Used in Crystallization  The addi-
tive included in the crystallization mix for purposes of 
inducing nucleation and crystal growth is referred to as 
the precipitant. Ammonium sulfate and the polyethylene 
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3.1.2.3.g Lipid Used in Bilayer Crystallization/NMR   For 
XRD records, this covers lipids used in crystallization by 
the so-called bilayer (cubic phase, vesicle fusion, bicelle) 
methods [reviewed in ref. 3]. To date, there are only four 
lipid species that have been used for this purpose. In the 
case of NMR entries, lipids are used to form bicelles and 
oriented bilayers with which to collect structure informa-
tion.
3.1.2.4  Non-Protein Components in Structure 
3.1.2.4.a All  A  listing  of  all  of  the  non-proteinaceous 
materials, other than water, that appear in the final struc-
ture are presented here. These can include ions, additives, 
precipitants, lipids, detergents, cofactors, prosthetic groups 
and pigments, among other things. The relevant data with 
which this field was populated was obtained directly from 
the ‘Heterogen’ entry in the corresponding PDB record. 
3.1.2.4.b Native Ligands  This is a subset of the compo-
nents listed in section 3.1.2.4.a that are a part of the na-
tive protein. Native ligands include pigments, prosthetic 
groups, ions and the like. 
3.1.2.4.c Co-crystallants  A co-crystallant is an ion, a 
small molecule or macromolecule (antibody fragment, 
for example) that was combined with the target protein 
for purposes of crystallizing it as a complex. 
3.1.2.5  Bibliographic Information
3.1.2.5.a Citation Title  This is the title of the primary 
citation as it appears in the PDB. Note that the primary 
citation may refer to a paper in which a refined version of 
the original model was reported. 
3.1.2.5.b  Journal  Name/Volume/Page/Publication Year/
Authors  The primary citation (journal reference) to the 
structure is listed here. The journal volume, start page 
number and year of publication, along with a complete 
listing of authors are included in the MPDB record. One 
of the records in the MPDB is based on a thesis and is so 
identified under Journal. 
A direct link to the corresponding publication in PubMed 
Central,  an  archive  of  life  sciences  journals  (http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=Pubmed), 
is available by way of the PubMed icon to the right of the 
‘Bibliographic Information’ heading. At the very least, an 
abstract of the article is posted there. In many cases, a full 
text pdf of the paper is also available for online viewing 
and/or download. 
3.1.2.5.c PDB Deposition Date  This refers to the date 
on which the structure coordinates were deposited in the 
PDB. It is important to note that refinements and correc-
tions  to  records  in  the  PDB  are  possible. When  major 
changes  are  made,  a  new  PDB  ID  is  assigned  which 
replaces the extant ID. The deposition date and the date 
of  publication  of  the  primary  citation  usually  coincide 
closely. However, in some early PDB records a significant 
mismatch exists. The photosynthetic reaction center from 
the  Rhodopseudomonas  (Blastochloris)  viridis  record 
(1PRC) is a case in point. It has a deposition date of 1988. 
Several revisions were made to the record between 1989 
and 1994. Publications cited date back to 1982, when first 
crystals were reported [4]. The original structure at 3 Å 
resolution was published in 1985 [5], and in 1995 a refined 
model was described [6]. 1995 is the publication year of 
the primary citation posted in the PDB and the MPDB. 
3.2  Searching the MPDB
One of the primary reasons for creating the MPDB was 
to provide a convenient interface with which the contents 
of the MPDB could be perused and interrogated with ef-
ficiency and ease. As noted, a somewhat limited but im-
mediate ‘Quick Search’ option is available from the Main 
Page. However, more complete and extensive searches can 
be conducted via the Search page, which is accessed from 
the Main Page by activating the Search links (fig. 2). 
The Search page has a list of alphabetically arranged 
options by means of which the MPDB can be queried. 
One of these, the PDB ID option, takes the user directly 
to an MPDB record. All others generate a table of records 
(summary table, fig. 4) the entries of which satisfy the 
search criteria. The nature of the search and the number 
of records found are shown above and to the right hand 
side of the summary table. The table includes the PDB 
ID,  title  and  spatial  resolution  associated  with  each 
record. Entries in the table are arranged by resolution. 
The user can go to the record of choice by clicking on the 
appropriate table entry. When the total number of records 
in a table exceeds 10, the remaining entries can be viewed 
on separate pages that are numbered to the bottom left of 
each table. The page number of the displayed page is 
shown in bold and black. 
Most queries are presented in the form of dropdown lists. 
List entries are arranged alphabetically for easy searching. 
The search options available in the MPDB are described 
individually below.
3.2.1  Author
A dropdown list of authors, alphabetized by last name, is 
available under the Author search option. 
3.2.2  Co-crystallant
The basis for this option has been described above (sec-
tion 3.1.2.4.c). 
3.2.3  Crystallization Method
The dropdown list for this query includes the following 
options: antibody, batch, bicelle, dialysis, epitaxial nu-
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microseeding, sitting drop, under oil, vapor diffusion and 
vesicle fusion. These are the descriptors used by authors 
to  identify  the  methods  used  for  crystallization.  The 
methods are not mutually exclusive. Thus, for example, 
the sitting drop and hanging drop methods are forms of 
vapor  diffusion. And  ‘batch’  includes  ‘under  oil’  and 
‘lipid cubic phase’ methods. At first, we had intended to 
devise and to implement a scheme that would properly 
describe these assorted crystallization methods and how 
they are related. But we felt that the new notation that 
would have to be introduced would not be familiar and 
would impede efficient use of the database. Such a ra-
tionalization of crystallization methods is badly needed. 
It will not be addressed further here.
3.2.4  Crystallization/Solubilization/Data Collection 
Conditions
This option enables the user to search the database based 
on one or several criteria in combination. There are four 
such criteria. The first concerns the detergent used in sol-
ubilizing the protein. This covers diffraction, microscopy 
and NMR-based records, since detergents are generally 
used  at  some  point  during  structure  determination  by 
virtually all methods. The second and third criteria refer 
to additives and precipitants employed in crystallization. 
The fourth covers lipids used in crystallization by the 
bilayer methods. For each of the four criteria, the user 
selects from a dropdown list. 
To perform a search based on just one of the four criteria, 
the user simply clicks on the dropdown list of choice, 
highlights a value on the list and submits the query. All 
other criteria windows are left unaltered, displaying the 
default value ‘ALL’. The latter indicates that the data 
bank is being searched under the selected criteria with 
all others unspecified and, thus, open to ALL values. The 
Customized Search, described next, uses the ALL fea-
ture extensively.
3.2.5  Customized Search
The Customized Search was created to enable the user 
to create and to run a query based on a combination of 
provided search keys. This is in contrast to the bulk of 
the other Search options that are based on just one or, at 
most, a few select keys. The user clicks on the appropri-
ate boxes and chooses from dropdown lists to specify the 
query. All other options within the Customized Search 
are left in their default settings. The search is run and 
the results are presented in tabular form. The record of 
choice  is  selected  from  within  the  summary  table  by 
point and click. 
3.2.6  Disposition in Membrane
This option enables the user to search the database with 
respect to the topology of the protein in or on the mem-
brane based on four possible choices.
3.2.7  Experimental Technique
It is here that the user gets to choose one of four methods 
by which structure was determined as follows: cryo-elec-
tron microscopy, electron diffraction, NMR and XRD.
3.2.8  Expression System
The basis for this option was described above (section 
3.1.2.1.k). 
3.2.9  Family 
The  basis  for  this  option  has  been  described  (section 
3.1.2.1.d). 
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3.2.10  Function 
The  basis  for  this  option  has  been  described  (section 
3.1.2.1.c). 
3.2.11  Journal 
The  journal  publishing  the  article  in  which  the  PDB 
record originated is listed here. One of the entries in the 
MPDB is based on a thesis and is identified as such. 
3.2.12  Name 
This refers to the name assigned to the protein by the au-
thors. But many proteins have formal as well as common 
names and abbreviations. As much as possible, all syno-
nyms are included in the Search by Name dropdown 
list to facilitate finding the protein of interest. Thus, for 
example, the Vitamin B12 receptor can be located under 
‘Vitamin B12 receptor’, ‘BtuB’, and ‘outer membrane 
cobalamin transporter’. There is also the option of enter-
ing the protein name, or part thereof, into a text dialog 
box. To use this option the default setting ‘None’ in the 
dropdown list must be selected. 
3.2.13  Native Ligand 
Many of the proteins listed in the MPDB contain natural 
pigments, cofactors and prosthetic groups. These can be 
searched for via the dropdown list identified under Native 
Ligand.
3.2.14  Non-Protein Component in Structure
This refers to components other than water that appear 
in the final structure and that are not naturally a part of 
the protein. They include ions, detergents, lipids, cofac-
tors, among others. By and large, such non-proteinaceous 
materials  derive  from  the  solutions  used  to  grow  the 
crystal upon which the structure is based. Some of the 
components have long and complex names. To make the 
dropdown list fit the screen, some of these names have 
been abbreviated. In such cases, the user should consult 
the PDB record for the full name. 
3.2.15  PDB ID
This is the identification code associated with the corre-
sponding record in the PDB. Records can be selected from 
a dropdown list or by entering text into a dialog box.
3.2.16  pH
In the case of records that are based on XRD data, this 
refers to the pH at which crystals were grown. For NMR-
based records, it is the pH of the solution used for data 
collection. A particular pH value or a range of pH values 
can be used to perform a search. Radio buttons enable 
the user to have included in the summary table records 
for which a pH value was not specified. In addition, the 
experimental technique used for structure determination 
can be selected so as to limit the search.
3.2.17  Publication Year
The year in which the primary citation reporting the par-
ticular PDB record was published can be used as a search 
criterion. (It is important to note that the Publication Year 
can differ from that when the PDB entry was made. In 
most cases, the latter PDB Deposition Date predates but 
is close in time to the year of publication. This is par-
ticularly true of late now that deposition in the PDB is 
generally a prerequisite for publication and refinements 
are not common. However, in the example cited above for 
the photosynthetic reaction center (section 3.1.2.5.c), the 
year of publication for the primary citation in the PDB is 
7 years post-deposition.) In addition to being able to spec-
ify a particular year, it is also possible to use this option to 
search over a selectable period from 1982 to 2005. 
Some fraction of records in the MPDB reside in a cat-
egory titled ‘To Be Published’. These represent struc-
tures that have been posted in the PDB, but for whatever 
reason, the authors have not gotten round to reporting in 
the literature. Radio buttons are provided so that the ‘To 
Be Published’ records are included or excluded from the 
summary table.
3.2.18  Resolution
The resolution with which a structure has been deter-
mined to is criterion upon which a search can be per-
formed. The posted resolution values extend from 0 to 10 
Å, and specific values, as well as ranges, can be searched. 
Resolution is reported for all techniques with the excep-
tion of NMR, in which case the resolution value entered 
is N/A. Radio buttons are provided that enable the user to 
include or exclude such records from the search results. 
3.2.19  Secondary Structure of Transmembrane Domain
This query enables the user to perform a search based 
on the dominant secondary structure of the membrane 
crossing  part  of  the  protein,  as  described  above  (sec-
tion 3.1.2.1.g ). For proteins with a-helical or b-barrel 
transmembrane domains, the search can be performed by 
specifying the number of membrane crossings.
3.2.20  Size
The size of a protein or peptide, or fragment thereof, as 
defined above (section 3.1.2.1.b) can be searched for un-
der this attribute. 
3.2.21  Source Organism
The source organism refers to the species of organism 
from which the protein was derived directly or by means 
of homo- or heterologous expression. 
3.2.22  Temperature
This is the temperature at which crystallogenesis was 
performed  or,  in  the  case  of  NMR-based  records,  the 
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of temperatures can be selected in addition to a single 
temperature. For several entries in the database an appro-
priate temperature could not be found in the PDB record 
and corresponding literature. In this case, the temperature 
value assigned is N/A. By means of radio buttons the user 
can choose to include or exclude such records in a given 
search. It is also possible to refine the temperature search 
by specifying the Experimental Technique.
3.3  Facts and figures 
An assortment of statistics can be generated online based 
on the contents of the MPDB. These can be accessed 
from the Main Page by way of the Statistics link (fig. 2). 
The user can choose the statistical data of interest from 
a dropdown list which, in turn, generates a table and a 
graphical  representation  of  the  data  (fig. 5).  The  plot 
takes the form of a histogram oriented horizontally to 
facilitate labeling and to make the independent variable 
entries more legible. The element with the highest record 
count is assigned the maximum bar length on a scale that 
is linear. Clicking on Count above the histogram enables 
the data to be sorted in order of increasing record count 
from top to bottom. A second click inverts the sort. The 
same feature applies to the heading above the table on 
the left. Clicking on it arranges table entries alphabeti-
cally and/or numerically. Statistics are calculated in SQL 
based on the latest weekly update. Those records that are 
included in a given count can be viewed by clicking on 
the given element or count in the table. 
Additional statistical analysis can be added in future ver-
sions of the MPDB. Users are encouraged to bring these 
to our attention. 
From the Statistics page the user can perform an analysis 
on the entire contents of the MPDB by simply clicking on 
the Pick a Statistic button and selecting from the drop-
down list. In this case, the default settings are retained for 
the other two features on the Statistics page. However, 
it is also possible to limit the scope of the analysis to 
one and/or two subsets of the database. In this case, the 
type of analysis is selected as above and the subset upon 
which the analysis is to be performed is chosen by select-
ing from the Experimental Technique and/or Crystal-
lization Method dropdown lists. Thus, for example, it 
is possible to perform an analysis of ‘number of records 
versus year’ over all entries in the MPDB. Or, by select-
ing the appropriate subsets, ‘annual record frequency’ 
can be obtained for those structures determined using 
‘XRD’ and the ‘hanging drop method’. 
In what follows, we describe the statistical analyses op-
tions that are currently available in the MPDB and later 
discuss them in terms of how the data might inform fu-
ture membrane protein crystallization endeavors. 
Figure 5. A screen shot of a 
default statistical analysis per-
formed on all MPDB records 
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3.3.1  Additive Used in Crystallization 
To  date,  63  different  additives  have  been  used  to  fa-
cilitate the crystallization of membrane proteins whose 
structures are reported in the MPDB. As noted, additives 
are  generally  small  amphiphiles  that  support  crystal-
logenesis. But since the definition is not strict and no 
convention has been accepted in regard to use of the term 
‘additive’, authors use the word with some abandon. As 
a result, the list of additives includes everything from 
small amphiphiles, to lipids, polymers and salts. Indeed, 
the most frequently encountered additive in the MPDB 
set is sodium chloride followed closely by 1,2,3-heptane-
triol. The next in order of popularity is glycerol, sodium 
azide (an antimicrobial agent), 2-methyl-2,4-pentanediol 
(MPD) and magnesium chloride (table 1).
3.3.2  Crystallization Method 
As explained above (section 3.1.2.3.a), the methods used 
for crystallizing membrane proteins with representation 
in the MPDB have been divided into 13 categories that 
Conditions, methods, systems  Count
Additive
1
  Sodium chloride   58
  1,2,3-Heptanetriol   56
  Glycerol   32
  Sodium azide   22
  2-Methyl-2,4-pentanediol   20
  Magnesium chloride   19
  EDTA   15
  Dithiothreitol   14
  1,6-Hexanediol   13
  Calcium chloride   13
Detergent
1
  N-Octyl-ß-d-glucopyranoside (OG)  97
  N,n-Dimethyldodecylamine-n-oxide (LDAO)  77
  Octyltetraoxyethylene (C8E4)   44
  N-Dodecyl-ß-d-maltopyranoside  38
  N-Decyl-ß-d-maltopyranoside  28
  Dodecylnonaoxyethylene (C12E9)  20
  N-Octyl-2-hydroxyethylsulfoxide  15
  Octylpolyoxyethylene  14
  CHAPSO  13
  N-Nonyl-ß-d-glucopyranoside  11
Precipitant
1
  Polyethylene glycol 4000   84
  Polyethylene glycol 400   39
  Ammonium sulfate   35
  Polyethylene glycol 2000   35
  Sodium/potassium phosphate   27
  Potassium phosphate   25
  Polyethylene glycol 600   23
  Polyethylene glycol monomethylether 2000   16
  Magnesium chloride   15
  2-Methyl-2,4-pentanediol   14
Temperature (°C)
1 
  20  96
  4  63
  18  35
  25  30
  22  27
  19  15
  23  15
  37  12
  16  7
  5  7
Conditions, methods, systems  Count
Crystallization Method
1,2 
  Vapor diffusion   324
  Hanging drop   145
  Sitting drop   125
  Batch   53
  Lipid cubic phase   38
  Dialysis   32
  Antibody   18
  Bicelle   13
  Microseeding   7
  Vesicle fusion   7
Expression System
3 
  Escherichia coli   198
  Synthetic   58
  Halobacterium salinarum   31
  Rhodobacter sphaeroides   31
  Pichia pastoris   10
  Spodoptera frugiperda   8
  Pseudomonas aeruginosa   2
  Wolinella succinogenes   1
  Thermus thermophilus   1
  Salmonella typhimuriam  1
Source organism
3 
  Escherichia coli   115
  Halobacterium salinarum   60
  Rhodobacter sphaeroides   49
  Homo sapiens   48
  Bos taurus   34
  Bacillus brevis   19
  Ovis aries   17
  Alicyclobacillus acidocaldarius   16
  Oryctolagus cuniculus   15
  Streptomyces lividans   12
Table 1. Conditions, methods and systems used in membrane protein and peptide structure determination and their contribution to record 
count in the MPD (the table includes the top 10 entries in each category arranged by record count). 
1 Refers to XRD records.
2 Not all methods are mutually exclusive.
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are not mutually exclusive. Thus, there is overlap between 
certain categories. To run the statistics on Crystallization 
Method, the only really useful option is to perform it 
under  default  conditions. This  generates  a  table  and  a 
plot showing record count versus method. A summary of 
records within a methods category can be obtained simply 
by clicking on the method or the count within the table. 
Of the crystallization methods available, vapor diffusion 
has been by far the most extensively used (table 1). Within 
this group, hanging drop with 145 records is ahead of the 
sitting drop approach with 125 records. Batch, followed 
successively by the lipidic cubic phase, dialysis, antibody 
and bicelle methods round out the other major contribu-
tors. The epitaxial nucleation, micro- and macroseeding, 
vesicle fusion and batch- under-oil methods have all con-
tributed to the total yield of membrane protein structures 
but in a less significant way in terms of numbers. It is 
important to note that the distribution owes its origin in 
part to the fact that vapor diffusion methods have been 
available to the community for the longest period. In con-
trast, the bicelle method is a relative newcomer. 
3.3.3  Detergent Used in Solubilization/NMR 
A  total  of  43  different  detergents  have  been  used  in 
protein structure determination studies across all of the 
methods represented in the MPDB. Octyl glucoside is 
by far the most extensively used, with LDAO taking up 
a close second position. C8E4, dodecyl maltoside, and 
decyl maltoside are in a lesser used group followed by 
C12E9 and dodecyl phosphatidylcholine. The distribution 
changes little when the statistical analysis is limited to 
XRD-based structures (table 1). However, for structures 
solved by NMR the dominant detergents include dodecyl 
phosphatidylcholine,  sodium  dodecyl  sulfate  and  di-
hexanoyl phosphatidylcholine. These facilitate solution 
structure determination as mixed micelles.
3.3.4  Experimental Technique 
The  default  statistical  analysis  shows  the  distribution 
of MPDB records across the four structure techniques. 
XRD accounts for 77%, while NMR represents 20%. The 
remaining records are shared between cryo-EM (1%) and 
electron diffraction (2%). Other search combinations un-
der Experimental Technique are possible but generally 
yield just single values. 
3.3.5  Expression System 
Across  all  experimental  techniques,  Escherichia  coli 
stands out as the most frequently used expression system 
with which to produce recombinant membrane proteins 
for  structure  determination  (table  1).  Rhodobacter 
sphaeroides and Halobacterium salinarum are also very 
popular, reflecting the fact that expression systems have 
been in place for both for some time. Less popular but 
still with representation within the body of structures are 
the  eukaryotes,  Pichia  (yeast)  and  Spodoptera  (insect 
cells). When examined from the point of view of XRD 
structures, the profile is essentially the same. The most 
important  ‘expression  system’  providing  structures  by 
the NMR route is ‘synthetic’ as man-made peptides.
3.3.6  Journal 
Over the entire database, the major journals publishing 
structures of membrane protein and peptides include J. 
Mol. Biol. (JMB) followed successively by Science, Na-
ture and Biochemistry. When the analysis is performed on 
XRD-based records, the order changes to Science, JMB 
and then Nature with Biochemistry, Structure, PNAS, and 
J. Biol. Chem. taking up the slack. When applied to NMR 
structures, the most popular outlets are Biochemistry fol-
lowed by JMB and Eur. J. Biochem., in that order.
3.3.7  Lipid Used in Bilayer Crystallization/NMR 
This refers to the bicelle, cubic phase and vesicle fusion 
methods for growing crystals. The most commonly used 
lipid within the group is monoolein, the lipid upon which 
the cubic phase method was founded. Dimyristoyl phos-
phatidylcholine is next on the list and is used exclusively 
for bicelle crystallogenesis. The third, most commonly 
used lipid in this category is referred to as the purple 
membrane lipids. They were employed to grow bacteri-
orhodopsin crystals by the vesicle fusion method. 
3.3.8  pH 
When performed over the entire database, the pH range 
used in successful membrane protein and peptide struc-
ture determinations extends from pH 1.4 to 10 (fig. 6). 
The most frequently used pH value (the mode) is 7.0, 
with large numbers of successes registered at pH 5.6, 
6.0,  6.5,  7.5  and  8.0.  Since  structures  determined  by 
Figure 6. pH dependence of the number of records in the MPDB 
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XRD represent ~80% of the records in the MPDB, the 
distribution is heavily weighted by the characteristics of 
this subset. Thus, repeating the analysis but limiting it to 
XRD-based structures gives a distribution similar to that 
obtained for the entire database.
The non-binned distribution that appears on the website 
under Statistics, with spikes at regular intervals of pH, 
very likely reflects the preferred (over-) sampling of the 
pH scale by investigators and by the use of crystalliza-
tion kits with set pH values. The question arises then 
as to the utility of the distribution in informing crystal-
logenesis trials. It does highlight the fact that the crys-
tallization of membrane proteins and peptides occurs 
over a very wide range of pH values. Thus, unless the 
protein loses activity, denatures or undergoes chemical 
modification,  or  the  lipids,  additives  and  precipitants 
used for protein solubilization and/or crystal growing 
are unstable, then it is appropriate to investigate the full 
range of pH values. 
3.3.9  Precipitant Used in Crystallization 
The panel of precipitants used in crystallization has 44 
entries. The most commonly employed is PEG 4000, 
with PEG 400 a distant second (table 1). Ammonium 
sulfate and PEG 2000 vie for third place. Sodium po-
tassium  phosphate  is  next  on  the  list,  followed  by 
potassium phosphate and PEG 600. This is across all 
crystallization methods that are dominated by the va-
por diffusion methods. When the statistics are run on 
the cubic phase method, sodium potassium phosphate 
is by far the most popular precipitant. Potassium and 
sodium chloride and PEG 4000 have also been used 
but with considerably lower frequency. The pattern is 
quite similar when performed on the batch crystalliza-
tion method. 
3.3.10  Source Organism 
The most frequently used source organism for all struc-
tures  in  the  MPDB  is  Escherichia  coli.  This  reflects 
the  popularity  of  the  organism  as  a  source  of  native 
membrane proteins as well as a system for homologous 
expression. The next most popular in order of frequency 
are Halobacterium salinarum and Rhodobacter sphaer-
oides (table 1). These, in turn, are sources for the bacte-
rial rhodopsins and the photosynthetic reaction centers, 
and their high count makes sense given the intensity with 
which these respective systems have been investigated. 
The pattern changes little when the statistics are run on 
XRD structures alone. However, when looked at from the 
NMR-based structures perspectives, the human source 
emerges with highest frequency. 
3.3.11  Temperature 
The  temperatures  used  to  solve  protein  and  peptide 
structures across all methods in the MPDB range from 
a low of 4 to a high of 60 °C. The mode is 20 °C, with 
4 °C assuming second place. The next most commonly 
used temperatures lie above and below the mode with a 
distribution that is skewed to the high temperature side. 
The distribution for XRD-based structures, as expected, 
is similar to that described, but the highest temperature 
employed drops to 37 °C (table 1). The mode in the case 
of NMR-based structures is 30 °C, with significant num-
bers of data being collected above 20 °C and up to 55 °C. 
This reflects the fact that the bulk of the NMR structures 
refer to peptides rather than proteins and that spectral 
quality generally improves with temperature.
3.3.12 Year 
The cumulative number of protein and peptide structures 
in the MPDB, across all experimental techniques for struc-
ture determination, has grown in a manner that is close 
to exponential in the period 1982 through 2004 (fig. 7). 
(Note that what is represented here is the Publication 
Year for the primary citation. As commented on above, 
it can differ significantly from the Deposition Date.) A 
similar function can be used to describe growth in the 
number of XRD-based structures. 2001 was a bumper 
year for NMR structures, and the following 2 years have 
witnessed  progressively  smaller  numbers  of  entries. 
However, based on the numbers thus far, 2005 looks like 
it will witness a very sizable output of such structures. It 
is important to note that the vast majority (88%) of NMR 
Figure 7. Dependence of the cumulative MPDB record count on the 
year of primary citation publication. The analysis was performed 
on all records in the MPDB (blue-green), on XRD records across 
all crystallization methods (red), and on XRD records in the lipidic 
cubic phase method subset (black). An exponential best fit to data in 
blue-green in the period 1982–2004 is shown as a solid black line. 
The equation for the line takes the form Y = A e
–B (X – 1982) where Y is 
cumulative count, X is year, A is 2.0 and B is 0.251. Note that the 
data for 2005 only include records for the first 6 months of that year 
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records refer to peptides. The authors have a particular 
interest in the lipidic cubic phase method for crystallizing 
membrane proteins. The corresponding annual statistics 
and those for all XRD-based structures are also shown 
alongside the overall membrane protein/peptide structure 
statistics in figure 7. 
3.4  Updating
The goal is to update the MPDB on a weekly basis. This 
will take place in parallel with the PDB, which is also a 
weekly event. A program has been written to query all 
PDB records that have been entered in the past week for 
those that contain the word ‘membrane’. Those records 
deemed appropriate by MPDB staff are processed, and 
relevant data and links are entered into the MPDB using 
a web interface. The database is time-stamped with the 
latest date on which updating occurred, and all statistics 
and current holding values are recalculated and posted. 
At the same time, PDB IDs that have been superseded 
are replaced in the MPDB with the new ID code. New 
records  are  compared  with  those  carrying  the  ‘To  Be 
Published’ flag and appropriately annotated.
3.5  Recommendations
First and foremost, the MPDB is a convenient and effi-
cient resource of information on membrane proteins and 
peptides. The bulk of the entries in the database refer to 
integral membrane proteins whose structure was solved 
by XRD. The latter subset of records can be mined for 
conditions that are compatible with successful crystal-
lization. What follows is a summary of the conditions 
that have been most useful in this regard across all such 
entries in the data bank. These include pH: 4.5–8.5; ad-
ditives:  sodium  chloride,  heptanetriol,  glycerol,  MPD, 
magnesium chloride; detergent: octyl glucoside, LDAO, 
C8E4, dodecyl maltoside, decyl maltoside, C12E9; precipi-
tant: PEG 4000, PEG 400, PEG 2000, ammonium sul-
fate, potassium phosphate, sodium potassium phosphate; 
temperature: 4 °C, 18–25 °C. 
It is appreciated that the above set of conditions has been 
culled from across all XRD records in the MPDB with-
out regard to source organism, membrane protein type 
and so on. However, given an entirely new protein with 
no known homologs in the MPDB, the above conditions 
represent a good starting point with which to begin the 
search for structure-grade crystals. 
3.6  The Future
The MPDB in its current incarnation represents a com-
promise of sorts. There is always a lot more that can be 
done to improve its appearance, functionality and scope. 
But each takes time and effort. Our hope is that what is 
being released in parallel with this publication is useful 
as it stands. We realize that there are errors and omis-
sions, although we have made every effort to keep these 
to a minimum. Users are requested to bring these to our 
attention for correction and to submit recommendation 
for how to improve the resource. 
In the interests of time, several protein characteristics are 
not in the current version of the MPDB. These include 
the  organelle  (mitochondrion,  chloroplast,  lysosome, 
nucleus,  etc.)  and  membrane  (endoplasmic  reticulum, 
bacterial outer membrane, plasmamembrane, sarcoplas-
mic reticulum, rod outer segment, ‘inclusion body’, etc.) 
source. The intent is to have this information in the next 
version of the data bank. 
Currently, MPDB records house data on the major chem-
ical components used to solve the structure of a given 
protein. The plan for the future is to augment this identity 
information with actual concentrations of the assorted 
materials used to effect crystallization, solubilization and 
dispersion. This will better lend itself to data mining for 
precise conditions supporting crystallization of particular 
membrane protein types. 
The statistics feature in the current MPDB is useful but 
is limited by the fixed number of searches the curators 
have made available. A later version of the data bank will 
provide the user with the ability to perform personalized 
statistical analysis on the data and to create online their 
own graphical representation of the results of a search 
that can be ported into a text document.
4  Conclusions
A web-based database of membrane protein and pep-
tide structure and function, the MPDB, has been re-
leased. It is updated weekly in parallel with the PDB. 
The database is searchable based on a host of criteria 
ranging from protein name and source organism to the 
method used to crystallize the protein for use in diffrac-
tion measurements. The vast majority of records in the 
database  refer  to  integral  membrane  proteins  whose 
structure was solved by crystallographic means. Statis-
tical analysis can be performed on the data online, and 
this feature has been used to identify conditions suitable 
for beginning crystallization trials on new membrane 
proteins. 
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